| Dr Talal M Ghazal, MD | |
|
1635 N George Mason Dr Ste 150, Arlington, VA 22205-3679 | |
| (571) 732-0044 | |
| (866) 850-1049 |
| Full Name | Dr Talal M Ghazal |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 23 Years |
| Location | 1635 N George Mason Dr Ste 150, Arlington, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700080520 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Holy Cross Hospital | Silver spring, MD | Hospital |
| Virginia Hospital Center | Arlington, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Medical Group Llc | 4385682061 | 1176 |
| John M Huffman Md Llc | 9830510643 | 2 |
News Archive
A new Tel Aviv University study finds that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis. Myelin sheaths are the "insulating tape" surrounding axons; axons carry electrical impulses in neurons.
The Association of Academic Health Centers (AAHC) launched the Education and Training Clinical Research Compliance Tool designed to assist academic health center leaders, research administrators, compliance and clinical trials office administrators, and directors of compliance education and training in strengthening and improving the development and implementation of clinical research compliance education and training programs.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Just 13 days in space may be enough to cause profound changes in eye structure and gene expression, report researchers from Houston Methodist, NASA Johnson Space Center, and two other institutions in the October 2013 issue of Gravitational and Space Research.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
› Verified 5 days ago
| Entity Name | Holy Cross Anesthesiology Associate, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376501007 PECOS PAC ID: 3577454313 Enrollment ID: O20040322001776 |
News Archive
A new Tel Aviv University study finds that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis. Myelin sheaths are the "insulating tape" surrounding axons; axons carry electrical impulses in neurons.
The Association of Academic Health Centers (AAHC) launched the Education and Training Clinical Research Compliance Tool designed to assist academic health center leaders, research administrators, compliance and clinical trials office administrators, and directors of compliance education and training in strengthening and improving the development and implementation of clinical research compliance education and training programs.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Just 13 days in space may be enough to cause profound changes in eye structure and gene expression, report researchers from Houston Methodist, NASA Johnson Space Center, and two other institutions in the October 2013 issue of Gravitational and Space Research.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
› Verified 5 days ago
| Entity Name | Privia Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013042480 PECOS PAC ID: 4385682061 Enrollment ID: O20050422000298 |
News Archive
A new Tel Aviv University study finds that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis. Myelin sheaths are the "insulating tape" surrounding axons; axons carry electrical impulses in neurons.
The Association of Academic Health Centers (AAHC) launched the Education and Training Clinical Research Compliance Tool designed to assist academic health center leaders, research administrators, compliance and clinical trials office administrators, and directors of compliance education and training in strengthening and improving the development and implementation of clinical research compliance education and training programs.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Just 13 days in space may be enough to cause profound changes in eye structure and gene expression, report researchers from Houston Methodist, NASA Johnson Space Center, and two other institutions in the October 2013 issue of Gravitational and Space Research.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
› Verified 5 days ago
| Entity Name | John M Huffman Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013538198 PECOS PAC ID: 9830510643 Enrollment ID: O20200603002163 |
News Archive
A new Tel Aviv University study finds that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis. Myelin sheaths are the "insulating tape" surrounding axons; axons carry electrical impulses in neurons.
The Association of Academic Health Centers (AAHC) launched the Education and Training Clinical Research Compliance Tool designed to assist academic health center leaders, research administrators, compliance and clinical trials office administrators, and directors of compliance education and training in strengthening and improving the development and implementation of clinical research compliance education and training programs.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Just 13 days in space may be enough to cause profound changes in eye structure and gene expression, report researchers from Houston Methodist, NASA Johnson Space Center, and two other institutions in the October 2013 issue of Gravitational and Space Research.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
› Verified 5 days ago
| Entity Name | Interventional Pain And Regenerative Medicine Specialists |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841072162 PECOS PAC ID: 3779928270 Enrollment ID: O20240223002249 |
News Archive
A new Tel Aviv University study finds that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis. Myelin sheaths are the "insulating tape" surrounding axons; axons carry electrical impulses in neurons.
The Association of Academic Health Centers (AAHC) launched the Education and Training Clinical Research Compliance Tool designed to assist academic health center leaders, research administrators, compliance and clinical trials office administrators, and directors of compliance education and training in strengthening and improving the development and implementation of clinical research compliance education and training programs.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Just 13 days in space may be enough to cause profound changes in eye structure and gene expression, report researchers from Houston Methodist, NASA Johnson Space Center, and two other institutions in the October 2013 issue of Gravitational and Space Research.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Talal M Ghazal, MD 1635 N George Mason Dr Ste 150, Arlington, VA 22205-3679 Ph: (571) 732-0044 | Dr Talal M Ghazal, MD 1635 N George Mason Dr Ste 150, Arlington, VA 22205-3679 Ph: (571) 732-0044 |
News Archive
A new Tel Aviv University study finds that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis. Myelin sheaths are the "insulating tape" surrounding axons; axons carry electrical impulses in neurons.
The Association of Academic Health Centers (AAHC) launched the Education and Training Clinical Research Compliance Tool designed to assist academic health center leaders, research administrators, compliance and clinical trials office administrators, and directors of compliance education and training in strengthening and improving the development and implementation of clinical research compliance education and training programs.
University of Texas at Arlington researchers are using an advanced computational approach or artificial intelligence to help experts assess learning difficulties in children very early in their lives.
Just 13 days in space may be enough to cause profound changes in eye structure and gene expression, report researchers from Houston Methodist, NASA Johnson Space Center, and two other institutions in the October 2013 issue of Gravitational and Space Research.
Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.
› Verified 5 days ago
Dr. Joyson Karakunnel, MD Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 1635 N. George Mason Dr., Suite 115, Arlington, VA 22205 Phone: 703-243-1310 Fax: 703-243-0128 |